We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GMDAQ market cap is 2.24M. The company's latest EPS is USD -0.4775 and P/E is -0.06.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.78M |
| Operating Income | -48.25M | -62.3M | -87.17M | -74.99M | -73.04M |
| Net Income | -34.35M | -72.7M | -89.79M | -79.38M | -63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 68.78M | 155.48M | 148.79M | 124.77M | 102.19M |
| Total Liabilities | 33.79M | 56.75M | 104.85M | 132.8M | 105.14M |
| Total Equity | 34.98M | 98.74M | 43.94M | -8.02M | -2.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -37.93M | -48.63M | -81.76M | -70.42M | -79.12M |
| Investing | 3.67M | 1.59M | -60.92M | 34.04M | -810k |
| Financing | 35.73M | 132.38M | 71.4M | 45.14M | 61.77M |
| Market Cap | 2.24M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 2.22 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | -1.34 |
| Dividend Yield | - |
| Shares Outstanding | 131.93M |
| Average Volume (1 week) | 332.75k |
| Average Volume (1 Month) | 384.77k |
| 52 Week Change | -19.05% |
| 52 Week High | 0.025 |
| 52 Week Low | 0.008 |
| Spread (Intraday) | 0 (12.82%) |
| Company Name | Gamida Cell Ltd (PK) |
| Address |
5 nahum heftsadie street jerusalem, jerusalem 91340 |
| Website | https://www.gamida-cell.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
